NBC News calls this “a setback for parents eager to vaccinate
[sic] their young children.”
Pfizer postpones FDA request for COVID vaccine for kids under 5
Feb. 11, 2022, 1:31 PM EST / Updated Feb. 11, 2022, 3:06 PM EST
By Berkeley Lovelace Jr.
Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years.
The move means that vaccines for this age group will not be available in the coming weeks, a setback for parents eager to vaccinate their young children
Pfizer said on Friday that it will wait for its data on a three-dose series of the vaccine, because it believes three doses “may provide a higher level of protection in this age group.” Data on the third dose is expected in early April, the company said.
Click on the link for the rest.